American Vanguard Corporation

American Vanguard Corporation (AVD) Market Cap

American Vanguard Corporation has a market capitalization of $76.1M.

Price: $2.66

0.15 (5.98%)

Market Cap: 76.09M

NYSE · time unavailable

CEO: Douglas A. Kaye

Sector: Basic Materials

Industry: Agricultural Inputs

IPO Date: 1987-03-03

Website: https://www.american-vanguard.com

American Vanguard Corporation (AVD) - Company Information

Market Cap: 76.09M|Sector: Basic Materials

Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.

Analyst Sentiment

92%
Strong Buy

From 1 Active Polls

1Y Forecast: $17.00

▲ +539.1% Potential Upside

Consensus Target Metrics

Low Bound

$14

Median

$17

High Bound

$20

Average

$17

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$17.00
▲ +539.10% Upside
Low Target
$14.00
426% Risk
Median Target
$17.00
539% Mid
High Target
$20.00
652% Max
Consensus
Buy
9 / 13 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)7671111164111124130149236
Enterprise Value ($M)288284290347305299286338453
Price to Earnings Ratio (P/E)-1.67-4.30-0.98-3.31-32.72-3.68-0.36-1.45-5.04
Price/Earnings-to-Growth Ratio (PEG)-0.04-2.80-0.01
Price to Sales Ratio (P/S)0.150.580.741.370.861.070.791.261.84
Price to Book Ratio (P/B)0.400.380.580.740.480.550.560.460.67
Price to Free Cash Flow Ratio (P/FCF)-1.87-1.9625.1714.53-5.60-5.914.015.59-14.64
Enterprise Value to Sales (EV/Sales)2.291.922.912.362.581.722.863.53
Enterprise Value to EBITDA (EV/EBITDA)-46.1549.38-16.38-114.4034.941495.73-25.20-14.94-115.21
Debt to Equity Ratio-33.971.490.990.910.900.820.720.610.66

AVD Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$2.66
Intrinsic Value$2.65
Market Alignment
Overvalued by 0.2%relative to calculated intrinsic value
9.00%
Exp: 0%0%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.01B
Perpetuity TV Value$0.15B
Discounted TV (PV)$0.06B
TV Weighting %57.5%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 AMER VANGUARD CORP (AVD) — Investment Overview

I can produce the requested institutional, moat-focused investment summary, but I need one key input to avoid material factual errors: AVD’s current operating segment(s) and what it primarily sells (product categories or business lines).

🧩 Business Model Overview

Please paste (or summarize) AVD’s business description from its most recent Form 10-K / investor presentation—specifically: the main lines of business, customer types (contractor/consumer/government), and how products/services are delivered (manufacturing vs. distribution; direct vs. channel).

💰 Revenue Streams & Monetisation Model

Confirm whether revenue is predominantly product sales, service/recurring, project-based, or subscription/usage-based, and whether customers receive consumables, replacements, or maintenance that create repeat purchasing.

🧠 Competitive Advantages & Market Positioning

Once I have the segment details, I will identify the correct structural moats (e.g., switching costs, network effects, regulatory barriers, logistics advantages) and name 2–3 direct competitors that match AVD’s exact industry focus.

🚀 Multi-Year Growth Drivers

I will map the 5–10 year growth thesis to the relevant TAM drivers (capacity/penetration, replacement cycle, channel expansion, or infrastructure build-out—depending on AVD’s industry).

⚠ Risk Factors to Monitor

I will tailor risks to the actual business (regulatory approvals, certification/qualification cycles, inventory/working-capital dynamics, customer concentration, input-cost volatility, and capex requirements—again depending on AVD’s segment).

📊 Valuation & Market View

I will explain the typical valuation framework used by the market for AVD’s peer group (e.g., EV/EBITDA, P/S, or valuation anchored to gross margin and working capital), without using any time-sensitive metrics.

🔍 Investment Takeaway

After you provide AVD’s segment/product description, I will deliver a high-conviction, evergreen thesis that is strictly moat-driven and formatted exactly as requested.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for AVD.

businesswire.com2026-06-01

Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #HodgkinLymphoma--BMS Announces Opdivo (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma.

seekingalpha.com2026-05-06

American Vanguard Corporation (AVD) Q1 2026 Earnings Call Transcript

American Vanguard Corporation (AVD) Q1 2026 Earnings Call Transcript

accessnewswire.com2026-05-06

American Vanguard Reports First Quarter 2026 Results

First Quarter Revenue Growth of 7% to $124 million Gross Margin Expansion of 500 bps Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 million NEWPORT BEACH, CA / ACCESS Newswire / May 6, 2026 / American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2026. Financial and Operational Highlights First Quarter 2026 - versus First Quarter 2025: Net sales of $124 million vs.

accessnewswire.com2026-05-04

American Vanguard Announces Date of First Quarter 2026 Earnings Release and Webcast Conference Call

NEWPORT BEACH, CA / ACCESS Newswire / May 4, 2026 / American Vanguard Corporation announced today that it will report financial results for the quarter ended March 31, 2026, on Wednesday, May 6, 2026, after the market closes. In addition, the company will conduct an earnings conference call on that day at 4:30 pm ET/ 1:30 pm PT. CEO Dak Kaye and CFO David Johnson will host the event.

defenseworld.net2026-04-11

Green Plains (NASDAQ:GPRE) & American Vanguard (NYSE:AVD) Financial Survey

Green Plains (NASDAQ: GPRE - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk. Risk and Volatility Green Plains has

defenseworld.net2026-04-05

Contrasting American Vanguard (NYSE:AVD) and Huabao International (OTCMKTS:HUIHY)

Huabao International (OTCMKTS:HUIHY - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Profitability This table compares Huabao International

defenseworld.net2026-03-25

Financial Comparison: International Flavors & Fragrances (NYSE:IFF) and American Vanguard (NYSE:AVD)

American Vanguard (NYSE: AVD - Get Free Report) and International Flavors and Fragrances (NYSE: IFF - Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Profitability This table compares American

seekingalpha.com2026-03-16

American Vanguard Corporation (AVD) Q4 2025 Earnings Call Transcript

American Vanguard Corporation (AVD) Q4 2025 Earnings Call Transcript

accessnewswire.com2026-03-13

American Vanguard Announces Date of Full Year 2025 Earnings Release and Webcast Conference Call

NEWPORT BEACH, CA / ACCESS Newswire / March 13, 2026 / American Vanguard® Company announced today that it will report financial results for the full year ending December 31, 2025, on Monday, March 16, after the market closes. The company will conduct an earnings conference call on that day at 4:30 pm ET/ 1:30 pm PT.

defenseworld.net2026-03-09

American Vanguard (AVD) Expected to Announce Earnings on Wednesday

American Vanguard (NYSE: AVD - Get Free Report) is expected to announce its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $163.00 million for the quarter. Individuals can find conference call details on the company's upcoming Q4 2025 earning

defenseworld.net2026-02-19

American Vanguard (NYSE:AVD) Stock Price Crosses Above 200-Day Moving Average – Time to Sell?

Shares of American Vanguard Corporation (NYSE: AVD - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $4.85 and traded as high as $5.35. American Vanguard shares last traded at $5.2440, with a volume of 134,157 shares changing hands. Analysts Set New Price

accessnewswire.com2026-01-14

American Vanguard Corporation Announces Executive Appointment and Relocation of Global Headquarters

NEWPORT BEACH, CA / ACCESS Newswire / January 14, 2026 / American Vanguard Corporation (NYSE:AVD) has announced, the following change to its executive management team. Mike DiPaola has been appointed Chief Commercial Officer.

defenseworld.net2025-12-25

Reviewing Mativ (NYSE:MATV) and American Vanguard (NYSE:AVD)

Mativ (NYSE: MATV - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Volatility and Risk Mativ has a beta

seekingalpha.com2025-11-28

American Vanguard Expects To Have A Good Q4

American Vanguard Corporation maintains a buy rating, supported by improving margins, disciplined OpEx, and attractive valuation amid a challenging agricultural market. AVD expects to generate ~$20 million in free cash flow in FY25, primarily in Q4, with a focus on debt reduction as a key priority. Gross margins are recovering as pricing pressures ease and destocking ends, while adjusted EBITDA has significantly improved due to cost controls.

defenseworld.net2025-11-16

Head to Head Survey: Minerals Technologies (NYSE:MTX) & American Vanguard (NYSE:AVD)

American Vanguard (NYSE: AVD - Get Free Report) and Minerals Technologies (NYSE: MTX - Get Free Report) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation. Valuation and Earnings This table compares

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"AVD reported Q1’26 revenue of $123.6M and net income of -$4.1M (EPS -$0.14). Revenue rose 6.7% QoQ ($115.8M in Q1’25 is not comparable QoQ, so QoQ comparison uses Q4’25), and was -17.9% YoY vs Q1’25 revenue of $115.8M? (YoY revenue change: +6.7% vs 2025-03-31 $115.8M; QoQ revenue change: -17.9% vs 2025-12-31 $150.7M). Net income improved sharply QoQ (from -$28.2M in Q4’25 to -$4.1M in Q1’26), but remained loss-making and was better YoY (-$8.5M in Q1’25 to -$4.1M in Q1’26). Gross margin improved sequentially (31.1% in Q1’26 vs 26.2% in Q4’25) and slightly declined YoY (31.1% vs 26.1% in Q1’25). Operating income of $1.9M flipped positive after a weak prior quarter (operating income +$1.9M vs +$6.0M in Q4’25; still below the profitability peak was earlier). Cash flow was a key swing factor: operating cash flow was -$35.4M in Q1’26, but cash balances increased to $70.9M, supported by financing inflows (+$95.0M). Total shareholder returns are weak: the stock is at $2.64 with -30.5% 1Y change and no dividend yield shown. Overall, the quarter shows improving profitability versus the prior quarter but unstable cash generation and continued losses."

Revenue Growth

Caution

QoQ revenue declined -18.0% (Q4’25 $150.7M → Q1’26 $123.6M) while YoY revenue increased +6.7% (Q1’25 $115.8M → Q1’26 $123.6M).

Profitability

Caution

Margins improved sequentially: gross margin expanded to 31.1% from 26.2% QoQ, and net loss narrowed to -3.4% from -18.7% QoQ. Net income improved QoQ (-$28.2M → -$4.1M) and YoY (-$8.5M → -$4.1M), with EPS at -$0.14.

Cash Flow Quality

Neutral

Operating cash flow deteriorated to -$35.4M in Q1’26 vs +$5.95M in Q4’25. Despite that, cash increased (+$58.5M) due to financing inflows; no dividends were paid and buybacks were minimal.

Leverage & Balance Sheet

Fair

Balance sheet resilience improved: cash rose to $70.9M and net debt turned negative (-$52.2M net debt) from strongly positive in prior quarters. Total assets increased to $665.2M from $596.5M, and equity was stable at $189.6M.

Shareholder Returns

Neutral

No dividend yield shown and 1Y price performance is weak (-30.53%). There is no indication of a >20% 1-year momentum tailwind.

Analyst Sentiment & Valuation

Caution

Street target consensus is $17 (high $20 / low $14) vs current price $2.64, implying significant upside. Valuation indicators appear optically depressed given losses, but the target suggests bullish sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

AVD delivered a strong Q1 2026 operating inflection, with net sales up 7% to $124M and adjusted EBITDA rising 245% to $10.3M. The key mechanical driver was margin expansion: gross margin increased 500 bps to 31% on higher-margin U.S. crop/specialty mix, improved factory efficiency, and continued cost control (operating expenses as a % of sales improved 120 bps). Management also demonstrated tangible execution on manufacturing footprint rationalization, shifting production to Axis, Alabama and targeting at least $4M annualized savings from the L.A. facility rationalization. Guidance reinforces the momentum: 2026 adjusted EBITDA of $44M–$48M on $530M–$550M sales. The main offset is international timing-driven weakness (Brazil and India down 7% overall). In Q&A, management attributed U.S. growth to volume (not pricing), acknowledged generics pressure (not yet impacting 2026 Folex cycle), and expects industry growth to be single digits in 2026, with uncertainty still elevated by liquidity and geopolitical disruptions.

AI IconGrowth Catalysts

  • U.S. crop business sales +17% driven primarily by herbicide and insecticide demand
  • Specialty business sales +6% led by OHP horticultural products
  • Launch of Mocap in Ecuador contributing to Central America improvement
  • Gross margin expansion to 31% from 26% (500 bps YoY) from higher-margin domestic mix and improved factory efficiency

Business Development

  • Central America demand improvement led by launch of Mocap in Ecuador

AI IconFinancial Highlights

  • Net sales $124M, +7% YoY (vs $116M prior year)
  • Adjusted EBITDA $10.3M, +245% YoY (from $3.0M), driven by higher-margin domestic volumes and improved gross margins
  • Gross profit margin expanded to 31% vs 26% prior year (+500 bps YoY)
  • Adjusted operating expenses (ex-transformation/impairment) 26.7% of sales vs 27.9% prior year (improvement of 120 bps)
  • Cash balance $71M vs $12M a year ago, reflecting refinancing term-loan structure replacing the revolver
  • Inventory $175M vs $185M in Q1 prior year (-$10M) attributed to supply chain discipline and SIOP improvements
  • Adjusted EBITDA outlook: $44M to $48M in 2026 on sales of $530M to $550M

AI IconCapital Funding

  • New capital structure: term loans replaced revolving working-capital facility
  • Total debt $267M at quarter end vs $166M at Q1 2025
  • Net debt approximately $196M vs $154M a year ago, mainly due to lower customer prepayments at end of 2025
  • Management intent to pay down debt over next 2 to 2.5 years and refinance afterward (timing contingent on market conditions)

AI IconStrategy & Ops

  • Manufacturing rationalization: shifted production from focused L.A. facility to Axis, Alabama
  • Annualized savings expected at least $4M from L.A. production rationalization
  • HQ relocation during the month (per prepared remarks) to reduce operating costs and improve accountability
  • Moved synthesis production to Alabama operation to optimize manufacturing footprint
  • Technology/system buildout highlighted as a priority to connect tools and improve execution
  • New product cadence target: 50 new product launches over next 5 years; $100M annualized revenue by 2030; fruits not fully visible until 2028

AI IconMarket Outlook

  • 2026 guidance: adjusted EBITDA $44M to $48M; sales $530M to $550M
  • Industry outlook: management expects agriculture industry to grow single digits in 2026 (not negative), with some “clean air” emerging despite commodity, weather/pest, and geopolitical uncertainties

AI IconRisks & Headwinds

  • Distributors showed no inclination to restock inventories despite worst of destocking appearing in the past
  • Farmer liquidity remains a top concern; growers making more last-minute crop decisions
  • Middle East disruptions: higher oil/natural gas/fertilizer prices; fertilization costs may affect next year’s crop decisions even if most purchases were already made for the current season
  • Geopolitical and macro uncertainty continues; commodities still below historically normal levels
  • Generics pressure is present; although branded products are “sticky,” specifically Folex generic pressure had not yet impacted 2026 sales because the company is not yet in that cycle
  • International revenue decline -7% YoY due to delivery timing comps in Brazil and reduced India sales tied to customer purchase timing

Q&A: Analyst Interest

  • Topic: Drivers of Q1 top-line growth (price vs volume). Management: Growth was primarily volume-driven in the U.S. crop business; management cited improved volume as the main contributor to the 17% U.S. increase and noted ongoing work to improve data granularity for future price/volume separations.
  • Topic: Generics impact on pricing/market share and which crops drove the U.S. strength. Management: Generics are entering meaningfully, but most products are “sticky” due to brand reputation; Folex generic pressure hasn’t hit 2026 yet. Impact and Aztec rose in Q1 while Metam was flat/slightly down, reflecting shifting purchase-timing dynamics.
  • Topic: Are ag-industry growth expectations aligned (low-single-digit) with AVD’s view. Management: Management agreed the industry should grow “single digits,” not contract, and highlighted ongoing uncertainty from geopolitics, commodities, weather, and pests. Management characterized the environment as having some “clean air” compared with prior periods but cautioned it could still turn.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the AVD Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for AVD.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (AVD)

© 2026 Stock Market Info — American Vanguard Corporation (AVD) Financial Profile